» Articles » PMID: 24652288

Regulation of Fibroblast Growth Factor-inducible 14 (Fn14) Expression Levels Via Ligand-independent Lysosomal Degradation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2014 Mar 22
PMID 24652288
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblast growth factor-inducible 14 (Fn14) is a highly inducible cytokine receptor that engages multiple intracellular signaling pathways, including nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK). Fn14 expression is regulated by several cytokines and growth factors, and Fn14 is transiently up-regulated after injury. In contrast, in states of chronic inflammatory disease and in some solid tumors, Fn14 is persistently up-regulated. However, the post-translational regulation of Fn14 expression has not been directly investigated. Thus, we examined Fn14 proteostasis in the presence and absence of the Fn14 ligand TNF-like weak inducer of apoptosis (TWEAK). Similar to other TNF receptor superfamily members, we found that TWEAK induces Fn14 internalization and degradation. Surprisingly, we also observed rapid, TWEAK-independent, constitutive Fn14 internalization and turnover. Fn14 levels are maintained in cell culture by ongoing synthesis and trafficking of the receptor, leading to subsequent down-regulation by lysosomal degradation. Unexpectedly, the extracellular domain of Fn14 is necessary and sufficient for constitutive turnover. Based on these findings, we propose a model in which constitutive down-regulation of Fn14 facilitates dynamic regulation of Fn14 protein levels and prevents spontaneous or inappropriate receptor signaling.

Citing Articles

Fn14-Directed DART Nanoparticles Selectively Target Neoplastic Cells in Preclinical Models of Triple-Negative Breast Cancer Brain Metastasis.

Carney C, Kapur A, Anastasiadis P, Ritzel R, Chen C, Woodworth G Mol Pharm. 2022; 20(1):314-330.

PMID: 36374573 PMC: 11056964. DOI: 10.1021/acs.molpharmaceut.2c00663.


TWEAK-Fn14 Axis Induces Calcium-Associated Autophagy and Cell Death To Control Mycobacterial Survival in Macrophages.

Chen Y, Liu P, Tang K, Liu H, Liao T Microbiol Spectr. 2022; 10(6):e0317222.

PMID: 36321903 PMC: 9769850. DOI: 10.1128/spectrum.03172-22.


Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.

Guner G, Assfalg M, Zhao K, Dreyer T, Lahiri S, Lo Y EMBO Mol Med. 2022; 14(10):e16084.

PMID: 36069059 PMC: 9549706. DOI: 10.15252/emmm.202216084.


Exocyst inactivation in urothelial cells disrupts autophagy and activates non-canonical NF-κB signaling.

Ortega M, Villiger R, Harrison-Chau M, Lieu S, Tamashiro K, Lee A Dis Model Mech. 2022; 15(10).

PMID: 36004645 PMC: 9586569. DOI: 10.1242/dmm.049785.


NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders?.

Roberti A, Chaffey L, Greaves D Biology (Basel). 2022; 11(3).

PMID: 35336746 PMC: 8945680. DOI: 10.3390/biology11030372.


References
1.
Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W . TWEAK attenuates the transition from innate to adaptive immunity. Cell. 2005; 123(5):931-44. DOI: 10.1016/j.cell.2005.09.022. View

2.
Zhou H, Hittelman W, Yagita H, Cheung L, Martin S, Winkles J . Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumors. Cancer Res. 2013; 73(14):4439-50. PMC: 3805367. DOI: 10.1158/0008-5472.CAN-13-0187. View

3.
Boucrot E, Saffarian S, Massol R, Kirchhausen T, Ehrlich M . Role of lipids and actin in the formation of clathrin-coated pits. Exp Cell Res. 2006; 312(20):4036-48. PMC: 2785547. DOI: 10.1016/j.yexcr.2006.09.025. View

4.
Anolik J, Looney R, Bottaro A, Sanz I, Young F . Down-regulation of CD20 on B cells upon CD40 activation. Eur J Immunol. 2003; 33(9):2398-409. DOI: 10.1002/eji.200323515. View

5.
Micheau O, Tschopp J . Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003; 114(2):181-90. DOI: 10.1016/s0092-8674(03)00521-x. View